Medscape Conference Coverage, based on selected sessions at the:
American Neurological Association (ANA) 132nd Annual Meeting
October 7 - 10, 2007, Washington, DC
This activity is not sanctioned by, nor a part of, the American Neurological Association.
Conference ReportConference News- Brain Stimulation Shows Promise in Chronic Stroke RecoveryNoninvasive transcranial direct current stimulation significantly improves recovery in severely affected chronic stroke patients and may provide a new therapeutic approach to facilitate recovery.
Medscape Medical News, October 25, 2007 - DWI May Help Establish Prognosis in Postarrest PatientsPreliminary findings suggest diffusion-weighted imaging may help differentiate between good and poor outcomes in patients who remain comatose after a resuscitated cardiac arrest.
Medscape Medical News, October 25, 2007 - Levodopa May Augment Recovery From Poststroke AphasiaLevodopa, in combination with speech and language therapy, may augment the recovery of stroke patients suffering from aphasia.
Medscape Medical News, October 19, 2007 - CABG Not a Contributor to Long-Term Cognitive DeclineContrary to previous findings, a new study suggests coronary artery bypass graft surgery does not contribute to long-term cognitive decline, which is rather related to underlying cerebrovascular disease.
Medscape Medical News, October 18, 2007 - US Poststroke Outcomes Poorer Among Minorities, WomenPoststroke outcomes in the United States are poorer among minorities and women -- with higher rates of rehospitalization among blacks and Hispanics and increased mortality in women, conclude 2 related studies.
Medscape Medical News, October 15, 2007 - Brain Death Guidelines Vary Widely at Top US Neurological HospitalsA new study shows major differences in brain death guidelines at the leading neurological hospitals in the United States, differences that might have implications for determination of death and initiation of transplant procedures.
Medscape Medical News, October 11, 2007 - Monoclonal Antibody Induces Remyelination in Animal Model of Multiple SclerosisA human monoclonal antibody administered in a single, low dose has been shown to induce remyelination in an animal model of multiple sclerosis.
Medscape Medical News, October 11, 2007 - Driving May Still Be Safe for Some After Dementia DiagnosisResults of a longitudinal study of drivers with dementia provides a natural history of the decline in driving ability over time and suggests at least some of those with mild cognitive impairments may be able to drive safely for extended periods with regular assessment.
Medscape Medical News, October 11, 2007 - Psychiatric Symptoms Have Greater Impact in Early vs Late PDA new study suggests that psychiatric symptoms that appear in tandem with advancing Parkinson's disease have a bigger impact on patients' quality of life in the early to middle vs later stages of disease.
Medscape Medical News, October 10, 2007 - Midlife Migraine With Aura Predicts Late-Life Brain InfarctsNew research suggests midlife migraine headache with visual aura predicts late-life cortical and cerebellar infarcts in old age.
Medscape Medical News, October 10, 2007 - Mirror Therapy Also Effective Against Lower-Limb Phantom PainResults of a randomized sham-controlled study suggest that mirror therapy, already shown to help reduce phantom limb pain for those with upper-limb amputations, can also help lower-limb amputees.
Medscape Medical News, October 9, 2007 - CHD, Diabetes, Linked to Worse Functional Outcomes in Women with Ischemic StrokeNew research shows that increased prestroke comorbidity, particularly diabetes and coronary heart disease, is independently associated with poorer poststroke functional status among women with ischemic stroke.
Medscape Medical News, October 9, 2007 - CME DNA Vaccine Alters Natural Course of Multiple SclerosisA newly developed DNA vaccine appeared to fundamentally alter the disease course of multiple sclerosis in patients with relapsing remitting multiple sclerosis.
Medscape Medical News, October 8, 2007
|
Legal Disclaimer
The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Neurological Association. These materials and the related activity are not sanctioned by the American Neurological Association or the commercial supporter of the conference and do not constitute an official part of that conference.
Copyright © 2007 Medscape.
